Amyotrophic Lateral Sclerosis Research Program (ALSRP) – Application

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Wednesday 3rd, July 2024

External Deadline: Wednesday 10th, July 2024


  • The Amyotrophic Lateral Sclerosis Research Program (ALSRP) released program announcements for the following funding opportunities:
  • – Clinical Outcomes and Biomarkers Award
  • – Pilot Clinical Trial Award
  • – Therapeutic Development Award
  • – Therapeutic Idea Award

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline.

All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the website (  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420. Applicant organizations must be registered in SAM ( and receive confirmation of an “Active” status before submitting an application through

Pre-Application: (Letter of Intent): May 24, 2024    5:00 p.m. Eastern time

New Deadline for ALSRP Letters of Intent – June 18, 2024 at 5:00 pm Eastern time

Application:  July 10, 2024  11:59 p.m. Eastern Time

See here for more information.

Funding Sources

Department of Defence - United States of America

This opportunity was posted by: RGCS

Last modified: April 25, 2024